| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $120.3M | +2.6% | +12.7% |
| R&D Expense | $29.5M | +0.6% | +0.5% |
| SG&A Expense | $17.5M | -8.2% | -10.9% |
| Operating Income | $3.7M | +348.1% | +127.0% |
| Pre-tax Income | $5.1M | +1010.3% | +136.7% |
| Income Tax | $854K | +170.2% | +93.2% |
| Net Income | $4.3M | +553.1% | +129.7% |
| EPS (Basic) | $0.07 | +600.0% | +128.0% |
| EPS (Diluted) | $0.07 | +600.0% | +128.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.4M | +8.2% | +30.1% |
| Accounts Receivable | $88.3M | +14.9% | +23.6% |
| Current Assets | $240.9M | +8.2% | +27.1% |
| Total Assets | $423.5M | +3.6% | +12.7% |
| Current Liabilities | $98.8M | -6.0% | -9.5% |
| Long-term Debt | $964K |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.5M | +4.3% | +167.4% |
| Capital Expenditures | $3.3M | +85.1% | +431.0% |
| Investing Cash Flow | -$6.7M | -28.1% | -59.4% |
| Financing Cash Flow | -$667K | +69.0% | +59.6% |
| Free Cash Flow | $12.2M | -6.7% | +135.9% |
| -58.4% |
| Total Liabilities | $103.1M | -6.8% | -14.8% |
| Stockholders' Equity | $320.3M | +7.5% | +25.8% |